The FDA continues to disregard the right of terminal patients to pursue life by ignoring a Citizen's Petition that urges the agency to allow the terminally ill access to experimental drugs, writes Steven Walker -- co-founder of the Abigail Alliance for Better Access to Developmental Drugs -- in this Wall Street Journal commentary. The Supreme Court can correct the FDA's misjudgments on this matter when it considers the alliance's petition today, Walker says.

Related Summaries